Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interventional Pulmonology Techniques for Benign Central Airway Fibrotic Stricture
NCT02287389Unknown
- Sponsor
- Tangdu Hospital
- Start
- Dec 2014
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of mitomycin c in central airway stenosis (CAS) (4 arms), sponsored by Tangdu Hospital. Primary endpoint: Percentage of cases with Level I and II remission at 3 months. Status: unknown.
02
Drugs
mitomycin c
03
Conditions
central airway stenosis (CAS)
Beyond the preview
Go deeper on NCT02287389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02287389.